Process analytical technologies committee meeting
Executive Summary
FDA's Pharmaceutical Science Advisory Committee will meet to discuss and provide comments on FDA's process analytical technologies draft guidance Oct. 21. On Oct. 22, the committee will discuss risk-based chemistry manufacturing and control and nomenclature proposals. The meeting will take place at the Best Western Gateway Hotel in Rockville, Md., beginning at 8:30 a.m. on both days. [To sign up to 1watch a webcast of the meeting, go to FDAAdvisoryCommittee.com.]...
You may also be interested in...
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.